Cancer-Related Pain
Cancer-related pain, which affects many cancer patients, can stem from the tumor itself, treatments, or diagnostic procedures, and may significantly impair quality of life. This pain is often chronic from the illness or acute from treatments, with medications prescribed based on its severity.
Health Outcomes
- Accelerated Recovery in Immunocompromised Mice
- Cancer-Related Supportive Effects
- Delayed Time to First Analgesic Request
- Improved Cancer-Related Health Outcome
- Improved Clinical Outcomes
- Improved Natural Killer Cell Function
- Improved Overall Patient Outcomes
- Improved Pain Intensity
- Improved Pain Management
- Improved Pain Score
- Improved Recovery in Immunocompromised Individuals
- Improved Secondary Outcomes
- Improved Specific Elements Within Assessed Measures
- Increased Analgesic Capacity
- Increased Cellular Adhesion
- Increased Dose Tolerance
- Increased Narcotic Consumption
- Increased Need for Repeated Dosing
- Increased Number of Pain-free Days
- Increased Pain
- Increased Pain-Free Days
- Increased Perceived Pain
- Increased Production of Bioactive Metabolites
- Modulated Nociceptive Signaling
- No Clinically Significant Safety or Tolerance Issues
- No Mutagenicity
- No Significant Change in Fatigue
- Normalized Expression of rhoB Gene
- Reduced Analgesic Use
- Reduced Apoptosis
- Reduced Average Pain
- Reduced Bodily Pain
- Reduced Interference Score
- Reduced Opioid Consumption
- Reduced Pain
- Reduced Pain Assessment Score
- Reduced Pain Attack
- Reduced Pain Duration
- Reduced Pain Frequency
- Reduced Pain Intensity
- Reduced Pain Medication Use
- Reduced Pain Scale
- Reduced Pain Score
- Reduced Pain Sensitivity
- Reduced Pain Severity
- Reduced Pain Symptom Score
- Reduced Pain Symptoms
- Reduced Pain-Related Disability
- Reduced Physical Symptoms
- Reduced Soreness
- Reduced Symptom Relief Latency
- Reduced Total Analgesic Dosage
- Reduced Total Morphine Consumption
- Reduced Unpleasantness
- Reduced Use of Pain Relieving Drugs
- Reduced Worst Pain
- Supportive Effect in Breast Cancer Management